94 related articles for article (PubMed ID: 10738901)
1. Total acid soluble and insoluble carnitine levels in human brain tumors.
Sandikci KS; Gümüstaş MK; Tüter Y; Kökoğlu E; Ozyurt E; Sözer V
Cancer Biochem Biophys; 1999 Jul; 17(1-2):49-57. PubMed ID: 10738901
[TBL] [Abstract][Full Text] [Related]
2. Profiles of the fatty acids in the plasma membrane of human brain tumors.
Kökoğlu E; Tüter Y; Yazici Z; Sandikci KS; Sönmez H; Ulakoğlu EZ; Ozyurt E
Cancer Biochem Biophys; 1998 Nov; 16(4):301-12. PubMed ID: 9925279
[TBL] [Abstract][Full Text] [Related]
3. Carnitine metabolism and human carnitine deficiency.
Tanphaichitr V; Leelahagul P
Nutrition; 1993; 9(3):246-54. PubMed ID: 8353366
[TBL] [Abstract][Full Text] [Related]
4. Q-modification of tRNAs in human brain tumors.
Aytaç U; Gündüz U
Cancer Biochem Biophys; 1994 Sep; 14(2):93-8. PubMed ID: 7889496
[TBL] [Abstract][Full Text] [Related]
5. Carnitine deficiency disorders in children.
Stanley CA
Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.
Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J
Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353
[TBL] [Abstract][Full Text] [Related]
7. Role of carnitine esters in brain neuropathology.
Virmani A; Binienda Z
Mol Aspects Med; 2004; 25(5-6):533-49. PubMed ID: 15363640
[TBL] [Abstract][Full Text] [Related]
8. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
9. [Physiological functions of carnitine and carnitine transporters in the central nervous system].
Inazu M; Matsumiya T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):113-20. PubMed ID: 18646596
[TBL] [Abstract][Full Text] [Related]
10. Characterization of lipids from human brain tissues by multinuclear magnetic resonance spectroscopy.
Tugnoli V; Tosi MR; Tinti A; Trinchero A; Bottura G; Fini G
Biopolymers; 2001; 62(6):297-306. PubMed ID: 11857268
[TBL] [Abstract][Full Text] [Related]
11. [The role of carnitine in human lipid metabolism].
Pietrzak I; Opala G
Wiad Lek; 1998; 51(1-2):71-5. PubMed ID: 9608835
[TBL] [Abstract][Full Text] [Related]
12. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
Virmani A; Gaetani F; Binienda Z
Ann N Y Acad Sci; 2005 Aug; 1053():183-91. PubMed ID: 16179522
[TBL] [Abstract][Full Text] [Related]
13. Levels of cadmium, lead, and mercury in human brain tumors.
Al-Saleh I; Shinwari N
Biol Trace Elem Res; 2001 Mar; 79(3):197-203. PubMed ID: 11354345
[TBL] [Abstract][Full Text] [Related]
14. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
Sasaki T; Lopes MB; Hankins GR; Helm GA
Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
[TBL] [Abstract][Full Text] [Related]
15. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells.
Peluso G; Petillo O; Margarucci S; Grippo P; Melone MA; Tuccillo F; Calvani M
J Cell Physiol; 2005 May; 203(2):439-46. PubMed ID: 15515015
[TBL] [Abstract][Full Text] [Related]
16. Carnitine in type 2 diabetes.
Mingrone G
Ann N Y Acad Sci; 2004 Nov; 1033():99-107. PubMed ID: 15591007
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.
Sorokina N; O'Donnell JM; McKinney RD; Pound KM; Woldegiorgis G; LaNoue KF; Ballal K; Taegtmeyer H; Buttrick PM; Lewandowski ED
Circulation; 2007 Apr; 115(15):2033-41. PubMed ID: 17404155
[TBL] [Abstract][Full Text] [Related]
18. Control of lipid oxidation during exercise: role of energy state and mitochondrial factors.
Sahlin K; Harris RC
Acta Physiol (Oxf); 2008 Dec; 194(4):283-91. PubMed ID: 18557841
[TBL] [Abstract][Full Text] [Related]
19. [Uridine diphosphate sugar in meningiomas of the brain].
Popova GM; Promyslov MSh; Gabibov GA
Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):30-1. PubMed ID: 8975513
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
